The Analysis of GILEAD SCIENCES, INC.'s Holdings & P&L


Currently, GILEAD SCIENCES, INC. holds 7 types of securities in its portfolio with a total value $2.1B. In the most recent quarter, they have increased their positions in RCUS (+31.4M shares, valued at $678.8M), GLPG (+16.7M shares, valued at $501.2M), N/A (+4.5M shares, valued at $125.0M); decreased their positions in ACLX (-6.7M shares, valued at $773.4M); initiated new positions in RCUS (+31.4M shares, valued at $678.8M), GLPG (+16.7M shares, valued at $501.2M), N/A (+4.5M shares, valued at $125.0M).


1M P&L
-27.2M-3.29%
3M P&L
+146.8M+22.50%
HY P&L
-59.5M-6.93%

P&L figures are estimated based on reported 13F stock holdings and market price changes. They are approximations and may not reflect actual fund performance. Stock split events may also affect the accuracy of these calculations, and we cannot guarantee that all splits have been fully accounted for.

Top Holding Treemap

Top Industries by Value

1Biotechnology2.0B
100.0%

Top Industries by Stock Count

1Biotechnology6 stocks
100.0%
Stock Holdings
ACLX
Arcellx Inc
0.00%
Shares6.7M
Event2026-03-31
Filed2026-05-08
RCUS
Arcus Biosciences Inc
New
Shares31.4M
Event2026-03-31
Filed2026-05-08
GLPG
Galapagos NV
New
Shares16.7M
Event2026-03-31
Filed2026-05-08
Assembly Biosciences Inc
Assembly Biosciences Inc
New
Shares4.5M
Event2026-03-31
Filed2026-05-08
KYTX
Kyverna Therapeutics Inc
New
Shares4.1M
Event2026-03-31
Filed2026-05-08
XLO
Xilio Therapeutics Inc
New
Shares650.4K
Event2026-03-31
Filed2026-05-08
-100.00%
Shares100
Event2026-04-28
Filed2026-04-28

Call Option Holdings
No call option holdings data available

Put Option Holdings
No put option holdings data available
GILEAD SCIENCES, INC. Institutional Holdings, Portfolio & P&L β€” TradeFomo